Longitudinal evaluation of the frequency of sexual intercourse and sexual activity in patients after nerve‐sparing robot‐assisted laparoscopic radical prostatectomy

2020 ◽  
Author(s):  
Shogo Inoue ◽  
Testutaro Hayashi ◽  
Jun Teishima ◽  
Akio Matsubara
Keyword(s):  
Radical Prostatectomy ◽  
Sexual Activity ◽  
Sexual Intercourse ◽  
Laparoscopic Radical Prostatectomy ◽  
Nerve Sparing ◽  
Robot Assisted ◽  
Longitudinal Evaluation

Topical alprostadil (Vitaros©) in the treatment of erectile dysfunction after non-nerve-sparing robot-assisted radical prostatectomy

2017 ◽  
Vol 85 (2) ◽  
pp. 55-59 ◽  
Author(s):  
Pier Andrea Della Camera ◽  
Simone Morselli ◽  
Gianmartin Cito ◽  
Giovanni Tasso ◽  
Nicola Laruccia ◽  
...  
Keyword(s):  
Erectile Dysfunction ◽  
Radical Prostatectomy ◽  
Sexual Intercourse ◽  
Performance Status ◽  
Eastern Cooperative Oncology Group ◽  
Nerve Sparing ◽  
Robot Assisted ◽  
Ecog Performance Status ◽  
Comorbidity Index

Objective: The aim of the study is the evaluation of the efficacy and safety of the treatment with topical alprostadil (Vitaros©) in post-robot assisted radical prostatectomy (RARP) rehabilitation therapy of patients with erectile dysfunction (ED). Methods: Seventy-four patients were enrolled and underwent non-nerve-sparing RARP. Inclusion criteria: age <75, preoperatively International Index of Erectile Function (IIEF-5) >16, erection hardness score (EHS) ⩾2, weekly sexual intercourse ⩾1, affirmative answers to Sexual Encounter Profile Question (SEP-Q) 2 and SEP-Q3, Charlson Comorbidity Index (CCI) ⩽5, Eastern Cooperative Oncology Group (ECOG) performance status ⩽1, no moderate/severe cardiovascular disease. Results: Vitaros was administered ⩾2 twice a week. At month 6, the IIEF-5 decreased from 20.5 preoperative to 18.1 post-treatment. EHS score decreased from a mean of 3.3 to a mean of 3.0. The quality of life score decreased from an average of 5.1 to 2.3. Weekly sexual intercourse decreased from an average of 2.1 to 1.7. Six patients dropped out; 89.7% patients showed a positive SEP-Q2 and 77.8% a positive SEP-Q3. All patients responded positively to Global Assessment Questions (GAQ)-1 and 97% to GAQ-2. Of all 68 analyzed patients, 13 (17.6%) switched to intracavernous injection therapy. Conclusions: In conclusion, Vitaros may become a viable alternative to common injective therapies in well-selected patients after RARP.

Effect of a Risk-stratified Grade of Nerve-sparing Technique on Early Return of Continence After Robot-assisted Laparoscopic Radical Prostatectomy

2013 ◽  
Vol 63 (3) ◽  
pp. 438-444 ◽  
Author(s):  
Abhishek Srivastava ◽  
Sameer Chopra ◽  
Anthony Pham ◽  
Prasanna Sooriakumaran ◽  
Matthieu Durand ◽  
...  
Keyword(s):  
Radical Prostatectomy ◽  
Laparoscopic Radical Prostatectomy ◽  
Nerve Sparing ◽  
Robot Assisted ◽  
Early Return

Is There Correlation of Nerve-Sparing Status and Return to Baseline Urinary Function After Robot-Assisted Laparoscopic Radical Prostatectomy?

2009 ◽  
Vol 23 (3) ◽  
pp. 489-493 ◽  
Author(s):  
Tristan Berry ◽  
Christopher Tepera ◽  
David Staneck ◽  
Bethany Barone ◽  
Raymond Lance ◽  
...  
Keyword(s):  
Radical Prostatectomy ◽  
Laparoscopic Radical Prostatectomy ◽  
Nerve Sparing ◽  
Urinary Function ◽  
Robot Assisted
Sign in / Sign up

Export Citation Format

Share Document